Stress and withdrawal from chronic ethanol induce selective changes in neuroimmune mRNAs in differing brain sites

Brain Sciences

Volumn 6, Issue 3, 2016, Pages

  Knapp, Darin J ^a   Harper, Kathryn M ^a   Whitman, Buddy A ^a,b   Zimomra, Zachary ^a   Breese, George R ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

526; Alcohol; Chronic ethanol withdrawal; CP154; CRF; Cytokine mRNAs; Restraint stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS;

EID: 85007304442     PISSN: None     EISSN: 20763425     Source Type: Journal    
DOI: 10.3390/brainsci6030025     Document Type: Article

References (69)

1. Overstreet, D.H., Knapp, D.J., Breese, G.R. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol. Clin. Exp. Res. 2002, 26, 1259-1268. [CrossRef] [PubMed]
2. Rassnick, S., Heinrichs, S.C., Britton, K.T., Koob, G.F. Microinjection of CRF antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 1993, 605, 25-32. [CrossRef]
3. Valdez, G.R., Zorrilla, E.P., Roberts, A.J., Koob, G.F. Antagonism of corticotropin releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 2003, 29, 55-60. [CrossRef]
4. Breese, G.R., Knapp, D.J., Overstreet, D.H. Stress sensitization of ethanol withdrawal-induced reduction in social interaction: Inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A receptor agonist. Neuropsychopharmacology 2004, 29, 470-482. [CrossRef] [PubMed]
5. Breese, G.R., Overstreet, D.H., Knapp, D.J., Navarro, M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: Inhibition by CRF-1 and benzodiazepine-receptor antagonists and a 5-HT1A receptor antagonists. Neuropsychopharmacology 2005, 30, 1662-1669. [CrossRef] [PubMed]
6. Breese, G.R., Sinha, R., Heilig, M. Chronic ethanol neuroadaptation and stress contribute to susceptibility for ethanol craving and relapse. Pharmacol. Ther. 2011, 129, 149-171. [CrossRef] [PubMed]
7. Sinha, R. How does stress increase risk of drug abuse and relapse? Psychopharmacology 2001, 158, 343-359. [CrossRef] [PubMed]
8. Breese, G.R., Knapp, D.J., Overstreet, D.H., Navarro, M., Wills, T.A., Angel, R.A. Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior. Neuropsychopharmacology 2008, 33, 867-876. [CrossRef] [PubMed]
9. Knapp, D.J., Whitman, B.A., Wills, T.A., Angel, R.A., Overstreet, D.H., Criswell, H.E., Ming, Z., Breese, G.R. Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain Behav. Immun. 2011, 25, S146-S154. [CrossRef] [PubMed]
10. Huang, M.M., Overstreet, D.H., Knapp, D.J., Angel, R., Wills, T.A., Navarro, M., Rivier, J., Vale, W., Breese, G.R. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is site specific and mediated by CRF-1 receptors: Relation to stress-induced sensitization. J. Pharmacol. Exp. Ther. 2010, 332, 298-307. [CrossRef] [PubMed]
11. Andersson, U., Tracey, K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Ann. Rev. Immunol. 2011, 29, 139-162. [CrossRef] [PubMed]
12. Fleshner, M. Stress-evoked sterile inflammation, danger associated molecular patterns (DAMLPs), microbial associated molecular patterns (MAMPS) and the inflammasome. Brain Behav. Immun. 2013, 27, 1-7. [CrossRef] [PubMed]
13. Suzuki, E., Shintani, F., Kanba, S., Asai, M., Nakaki, T. Immobilization stress increases mRNA levels of interleukin-1 receptor antagonist in various rat brain regions. Cell Mol. Neurobiol. 1997, 17, 557-562. [CrossRef] [PubMed]
14. Park, J.S., Svetkauskaite, D., He, Q., Kim, J.Y., Strassheim, D., Ishizaka, A., Esward, A. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 2004, 279, 7370-7377. [CrossRef] [PubMed]
15. Park, J.S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J.Y., Strassheim, D., Sohn, J.W., Yamada, S., Maruyama, I., Banerjee, A., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 2006, 290, C917-C924. [CrossRef] [PubMed]
16. Bianchi, M.E. HMGB1 Loves Company. J. Leukoc. Biol. 2009, 86, 573-576. [CrossRef] [PubMed]
17. Barnum, C.J., Blandino, P., Jr., Deak, T. Social status modulates basal IL-1 concentrations in the hypothalamus of pair-housed rats and influences certain features of stress reactivity. Brain Behav. Immun. 2008, 22, 517-527. [CrossRef] [PubMed]
18. Blandino, P., Barnum, C.J., Solomon, L.G., Larish, Y., Lankow, B.S., Deak, T. Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress. Brain Behav. Immun. 2009, 23, 958-968. [CrossRef] [PubMed]
19. Deak, T., Bordner, K.A., McElderry, N.K., Barnum, C.J., Blandino, P., Jr., Deak, M.M., Tammariello, S.P. Stress-induced increases in hypothalamic IL-1: A systematic analysis of multiple stressor paradigms. Brain Res. Bull. 2005, 64, 541-556. [CrossRef] [PubMed]
20. Girotti, M., Donegan, J.J., Morilak, D.A. Chronic intermittent cold stress sensitizes neuroimmune reactivity in the rat brain. Psychoneuroendocrinology 2011, 36, 1164-1174. [CrossRef] [PubMed]
21. Hueston, C.M., Barnum, C.J., Eberle, J.A., Ferraioli, F.J., Buck, H.M., Deak, T. Stress-dependent changes in neuroinflammatory markers observed after common laboratory stressors are not seen following acute social defeat of the Sprague Dawley rat. Physiol. Behav. 2011, 104, 187-198. [CrossRef] [PubMed]
22. Johnson, J.D., Campisi, J., Sharkey, C.M., Kennedy, S.L., Nickerson, M., Greenwood, B.N., Fleshner, M. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005, 135, 1295-1307. [CrossRef] [PubMed]
23. Minami, M., Kuraishi, Y., Yamaguchi, T., Nakai, S., Hirai, Y., Satoh, M. Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus. Neurosci. Lett. 1991, 123, 254-256. [CrossRef]
24. Nguyen, K.T., Deak, T., Owens, S.M., Kohno, T., Fleshner, M., Watkins, L.R., Maier, S.F. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J. Neurosci. 1998, 18, 2239-2246. [PubMed]
25. Nguyen, K.T., Deak, T., Will, M.J., Hansen, M.K., Hunsaker, B.N., Fleshner, M., Watkins, L.R., Maier, S.F. Time course and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1beta protein response to acute stress. Brain Res. 2000, 859, 193-201. [CrossRef]
26. Vecchiarelli, H.A., Gandhi, C.P., Gray, J.M., Morena, M., Hassan, K.I., Hill, M.N. Divergent responses of inflammatory mediators within the amygdala and medial prefrontal cortex to acute psychological stress. Brain Behav. Immun. 2016, 51, 70-91. [CrossRef] [PubMed]
27. Crews, F.T., Zou, J., Qin, L. Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav. Immun. 2011, 25, S4-S12. [CrossRef] [PubMed]
28. Crews, F.T., Qin, L., Sheedy, D., Vetreno, R.P., Zou, J. High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence. Biol. Psychiatry 2013, 73, 602-612. [CrossRef] [PubMed]
29. Dodd, S., Maes, M., Anderson, G., Dean, O.M., Moylan, S., Berk, M. Putative neuroprotective agents in neuropsychiatric disorders. Prog. Neuropsychopharm. Biol. Psychiatry 2013, 42, 135-145. [CrossRef] [PubMed]
30. Felger, J.C., Lotrich, F.E. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience 2013, 246, 199-229. [CrossRef] [PubMed]
31. Hammen, C. Stress and Depression. Annu. Rev. Clin. Psychol. 2005, 1, 293-319. [CrossRef] [PubMed]
32. Koob, G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2008, 56, 18-31. [CrossRef] [PubMed]
33. Krueger, J.M., Rector, D.M., Churchill, L. Sleep and cytokines. Sleep Med. Clin. 2007, 2, 161-169. [CrossRef] [PubMed]
34. Miller, A.H., Maletic, V., Raison, C.L. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol. Psychiat. 2009, 65, 732-741. [CrossRef] [PubMed]
35. Shin, L.M., Liberzon, I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010, 35, 169-191. [CrossRef] [PubMed]
36. Frye, G.D., McCown, T.J., Breese, G.R. Characterization of susceptibility to audiogenic seizures in ethanol-dependent rats after microinjection of gamma-aminobutyric acid (GABA) agonists into the inferior colliculus, substantia nigra or medial septum. J. Pharmacol. Exp. Ther. 1983, 227, 663-670. [PubMed]
37. McCown, T.J., Breese, G.R. Multiple withdrawals from chronic ethanol “kindles” inferior collicular seizure activity: Evidence for kindling of seizures associated with alcoholism. Alcohol. Clin. Exp. Res. 1990, 14, 394-399. [CrossRef] [PubMed]
38. Whitman, B.A., Knapp, D.J., Werner, D.F., Crews, F.T., Breese, G.R. The cytokine-mRNA Increase induced by withdrawal from chronic ethanol in the sterile environment of brain is mediated by CRF and HMGB1 Release. Alcohol. Clin. Exp. Res. 2013, 37, 2086-2097. [CrossRef] [PubMed]
39. Porterfield, V.M., Zimomra, Z.R., Caldwell, E.A., Camp, R.M., Gabella, K.M., Johnson, J.D. Rat strain differences in restraint stress-induced brain cytokines. Neuroscience 2011, 188, 48-54. [CrossRef] [PubMed]
40. Overstreet, D.H., Knapp, D.J., Breese, G.R. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats. Alcohol Clin. Exp. Res. 2007, 31, 1473-1481. [CrossRef] [PubMed]
41. Faraco, G., Fossati, S., Bianchi, M.E., Patrone, M., Pedrazzi, M., Sparatore, B., Moroni, F., Chiarugi, A. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J. Neurochem. 2007, 103, 590-603. [CrossRef] [PubMed]
42. Akira, S., Takeda, K. Toll-like receptor signaling. Nat. Rev. Immunol. 2004, 4, 499-511. [CrossRef] [PubMed]
43. Yamada, S., Maruyama, I. HMGB1, a novel inflammatory cytokine. Clin. Chim. Acta 2007, 375, 36-42. [PubMed]
44. Yang, H., Wang, H., Czura, C.J., Tracey, K.J. The cytokine activity of HMGB1. J. Leukoc. Biol. 2005, 78, 1-8. [CrossRef] [PubMed]
45. Yu, M., Wang, H., Ding, A., Golenbock, D.T., Latz, E., Czura, C.J., Fenton, M.J., Tracey, K.J., Yang, H. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006, 26, 174-179. [CrossRef] [PubMed]
46. Knapp, D.J., Overstreet, D.H., Breese, G.R. Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands. Alcohol Clin. Exp. Res. 2005, 29, 553-563. [CrossRef] [PubMed]
47. Shizuya, K., Komori, T., Fujiwara, R., Miyahara, S., Ohmori, M., Nomura, J. The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat. Life Sci. 1997, 61, 135-140. [CrossRef]
48. He, J., Crews, F.T. IncreasedMCP-1 and microglia in various regions of the human alcoholic brain. Exp. Neurol. 2008, 210, 349-358. [CrossRef] [PubMed]
49. Pascual, M., Baliño, P., Aragón, C.M., Guerri, C. Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: Role of TLR4 and TLR2. Neuropharmacology 2015, 89, 352-359. [CrossRef] [PubMed]
50. Crews, F.T., Vetreno, R.P. Neuroimmune basis of alcoholic brain damage. Int. Rev. Neurobiol. 2014, 118, 315-357. [PubMed]
51. Crews, F.T., Vetreno, R.P. Mechanisms of neuroimmune gene induction in alcoholism. Psychopharmacology (Berl.) 2016, 333, 1543-1547. [CrossRef] [PubMed]
52. Liu, Y., Qin, L., Wilson, B., Wu, X., Qian, L., Granholm, A.C., Crews, F.T., Hong, J.S. Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits. Neurotoxicology 2008, 29, 864-870. [CrossRef] [PubMed]
53. Funk, C.K., O’Dell, L.E., Crawford, E.F., Koob, G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 2006, 26, 11324-11332. [CrossRef] [PubMed]
54. Buck, H.M., Hueston, C.M., Bishop, C., Deak, T. Enhancement of the hypothalamic-pituitary-adrenal axis but not cytokine responses to stress challenges imposed during withdrawal from acute alcohol exposure in Sprague-Dawley rats. Psychopharmacology 2011, 218, 203-215. [CrossRef] [PubMed]
55. Baldwin, H.A., Rassnick, S., Rivier, J., Koob, G.F., Britton, K.T. CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat. Psychopharmacology 1991, 103, 227-232. [CrossRef] [PubMed]
56. Ming, Z., Criswell, H.E., Breese, G.R. Evidence for TNF action on excitatory and inhibitory neurotransmission in the central amygdala: A brain site influenced by stress. Brain Behav. Immun. 2013, 33, 102-111. [CrossRef] [PubMed]
57. Breese, G.R., Knapp, D.J. Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF. Alcohol 2016, 52, 9-23. [CrossRef] [PubMed]
58. June, H.L., Liu, J., Warnock, K.T., Bell, K.A., Balan, I., Bollion, D., Puche, A., Aurelian, L. CRF-amplified neuronal TLR4/MCP-1 signaling regulates alcohol self-administration. Neuropsychopharmacology 2015, 40, 1549-1559. [CrossRef] [PubMed]
59. Freeman, K., Brureau, A., Vadigepalli, R., Staehle, M.M., Brureau, M.M., Gonye, G.E., Hoek, J.B., Hooper, D.C., Schwaber, J.S. Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei. J. Neuroinflamm. 2012, 9, 97. [CrossRef] [PubMed]
60. Breese, G.R., Overstreet, D.H., Knapp, D.J. Conceptual framework for the etiology of alcoholism: A “kindling”/stress hypothesis. Psychopharmacology 2005, 178, 367-380. [CrossRef] [PubMed]
61. Heilig, M., Koob, G.F. A key role of corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007, 30, 399-406. [CrossRef] [PubMed]
62. Blednov, Y.A., Bergeson, S.E., Walker, D., Ferreira, V.M.M., Kuziel, W.A., Harris, R.A. Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol. Behav. Brain Res. 2005, 165, 110-125. [CrossRef] [PubMed]
63. Blednov, Y.A., Ponomarev, I., Geil, C., Bergeson, S., Koob, G.F., Harris, R.A. Neuroimmune regulation of alcohol consumption: Behavioral validation of genes obtained from genomic studies. Addict. Biol. 2012, 17, 108-120. [CrossRef] [PubMed]
64. Robinson, G., Most, D., Ferguson, L.B., Mayfield, J., Harris, R.A., Blednov, Y.A. Neuroimmune pathways in alcohol consumption: Evidence from behavioral and genetic studies in rodents and humans. Int. Rev. Neurobiol. 2014, 118, 13-39. [PubMed]
65. Valenta, J.P., Gonzales, R.A. Chronic Intracerebroventricular Infusion of Monocyte Chemoattractant Protein-1 leads to a persistent increase in sweetened ethanol consumption during operant self-administration but does not influence sucrose consumption in Long-Evans rats. Alcohol. Clin. Exp. Res. 2016, 40, 187-195. [CrossRef] [PubMed]
66. Lotrich, F.E. Psychiatric clearance for patients started on interferon-alpha-based therapies. Am. J. Psychiatry 2013, 170, 592-597. [CrossRef] [PubMed]
67. Raison, C.L., Miller, A.H. Malaise, melancholia and madness: The evolutionary legacy of an inflammatory bias. Brain Behav. Immun. 2013, 31, 1-8. [CrossRef] [PubMed]
68. Iwata, M., Ota, K.T., Duman, R.S. The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses. Brain Behav. Immun. 2013, 31, 105-114. [CrossRef] [PubMed]
69. Sinha, R., Fox, H.C., Hong, K.I., Hansen, J., Tuit, K., Kreek, M.J. Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent ethanol relapse and treatment outcomes. Arch. Gen. Psychiat. 2011, 68, 942-952. [CrossRef] [PubMed]